Cat. No. | Product name | CAS No. |
DCC5484 |
vuf14480
Partial agonist in hH 4 R-mediated G protein signalling and β-arrestin2 recruitment, bounding covalently to the hH4R |
1605304-31-1 |
DCC5485 |
Vuf14738
Novel robust and fatigue-resistant photoswitchable GPCR antagonist |
2223027-70-9 |
DCC5486 |
Vuf14862
Novel robust and fatigue-resistant photoswitchable GPCR antagonist |
2223023-78-5 |
DCC5487 |
Vuf15259
Novel inhibitor of Hbp secretion, activating σE stress, impairing Hbp secretion and decreasing the abundance of OMPs, consistent with impaired BAM function |
|
DCC5488 |
Vuf15888
Novel photoswitchable modulator of the CXCR3 chemokine receptor |
|
DCC5489 |
Vuf16216
Novel CXCR3 ligand, photoswitching from antagonism to agonism |
|
DCC5490 |
Vuf16620
Novel photoswitchable modulator of the CXCR3 chemokine receptor |
|
DCC5491 |
vuf5228
Histamine H3 receptor antagonist |
785767-25-1 |
DCC5492 |
Vuf5391
H3R inverse agonist |
|
DCC5493 |
vuf5455
Adenosine A3 receptor (A3AR) allosteric modulator |
390817-85-3 |
DCC5494 |
Vuf5834
Novel full inverse agonist at CXCR3 N3.35A |
860002-95-5 |
DCC5495 |
Vuf-6884
Full agonist of hH4R with ~300-fold selectivity over hH3R and hH2R, but showing potent inverse agonistic activity at hH1R |
3455-10-5 |
DCC5496 |
Vuf-8430
Potent histamine H4 receptor full agonist |
98021-17-1 |
DCC5497 |
Vuf8504
Allosteric modulator of A3 adenosine receptors |
112575-50-5 |
DCC5498 |
Vx-710
Multidrug resistance inhibitor |
159997-94-1 |
DCC5499 |
Vzmc013
Novel Probe of Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity |
|
DCC5500 |
w-13 Hydrochloride
Featured
W-13 hydrochloride is a calmodulin antagonist. W-13 hydrochloride can inhibit Tamoxifen (HY-13757A)-resistant human breast cancer cell growth. |
88519-57-7 |
DCC5501 |
w-5 Hydrochloride
Calmodulin antagonist, inhibiting Ca2+/calmodulin-regulated enzyme activities |
61714-25-8 |
DCC5502 |
waladin1
Mixed competitive/noncompetitive inhibitor of |
1170611-39-8 |
DCC5503 |
Wallichoside
Nocel inhibitor of BMI1 promoter activity, decreasing BMI1 protein levels in HCT116 human colon carcinoma cells, significantly reducing levels of the CSC biomarker epithelial cell adhesion molecule and diminishing the self-renewal capability of CSCs |
31087-88-4 |
DCC5504 |
Way103
Very late adhesion molecule 4 (VLA-4) antagonist, inhibiting VLA-4/VCAM-1 ligation as a means of modulating eosinophil functions beyond its action on cell adhesion and migration |
|
DCC5505 |
Way-123783
SGLT2 inhibitor |
152595-59-0 |